Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.

Yes, researchers argue, vitamin D supplements help protect the heart
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.
FDA approves Bayer's finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
Statin use may protect patients from subarachnoid hemorrhages
Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.
FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy
The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.
FDA finalizes new heart warnings for COVID-19 vaccines
The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.

Bayer ends blood thinner trial early due to lack of efficacy

The Independent Data Monitoring Committee recommended Bayer stop the trial due to the drug's poor performance compared to apixaban.

ADHD medications associated with heightened CVD risk

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained.

Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes

Novo Nordisk shared initial results from the SELECT trial back in August, but now the full analysis—which includes data from more than 17,000 patients—has been published in The New England Journal of Medicine.

Rasha Al-Lamee, MBBS, PhD, a cardiologist with the National Heart and Lung Institute in London

PCI benefits patients with stable chest pain, late-breaking data confirm

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said.

tirzepatide injections Zepbound Eli Lilly

FDA approves diabetes drug tirzepatide for chronic weight management under new name

The FDA issued its own statement about the approval, highlighting the importance of taking the drug in combination with an improved diet and regular physical activity.

Video of Patrick McGill, MD, explaining how Community Health Network in Indiana eliminated more than 5 million nuisance alerts.

Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

"Changing just six alerts in the system knocked out about 5 million alerts annually," explained Patrick McGill, MD, executive vice president and chief transformation officer at CHN.

private equity corporatization business consolidation

Private equity-backed pharmaceutical company acquires stroke drug from Bayer

The drug, nimodipine, is a second-generation calcium channel blocker designed to prevent and treat cerebral vasospasm following an aneurysmal subarachnoid hemorrhage.

Pharmaceutics

Yes, researchers argue, vitamin D supplements help protect the heart

FDA approves Bayer's finerenone to treat wide range of heart failure patients

Statin use may protect patients from subarachnoid hemorrhages

FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy

FDA finalizes new heart warnings for COVID-19 vaccines